Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma

This is the authors' abstract. We don't add key points for this paper.

BACKGROUND: Treating asthma with a combination of inhaled corticosteroid and a long-acting beta-2-agonist is often preferred when asthma is not controlled when using a low-medium dose of an inhaled corticosteroid. OBJECTIVE: To review the pharmacology, efficacy and safety of inhalers containing combinations of long-acting bronchodilators and inhaled corticosteroids to treat moderate-to-severe, persistent asthma. METHODS: Using a list of keywords, we conducted a PubMed search of the literature. Data provided by the manufacturer were also reviewed. RESULTS: Fluticasone propionate with salmeterol and budesonide with formoterol are both well tolerated, have equal clinical efficacy and have recent data affirming their safe use in diverse patient populations. CONCLUSIONS: Combination inhalers improve asthma control in patients previously uncontrolled on inhaled corticosteroids.